erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines

por Knowlden, Janice M, Gee, Julia MW, Barrow, Denise, Robertson, John F, Ellis, Ian O, Nicholson, Robert I, Hutcheson, Iain R
Publicado 2011

Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

por Hutcheson, Iain R, Knowlden, Janice M, Hiscox, Steve E, Barrow, Denise, Gee, Julia MW, Robertson, John F, Ellis, Ian O, Nicholson, Robert I
Publicado 2007

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1

por Hutcheson, Iain R, Goddard, Lindy, Barrow, Denise, McClelland, Richard A, Francies, Hayley E, Knowlden, Janice M, Nicholson, Robert I, Gee, Julia MW
Publicado 2011

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro

por Jordan, Nicola J, Dutkowski, Carol M, Barrow, Denise, Mottram, Huw J, Hutcheson, Iain R, Nicholson, Robert I, Guichard, Sylvie M, Gee, Julia MW
Publicado 2014

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

por Hutcheson, Iain R., Knowlden, Janice M., Hiscox, Steve E., Barrow, Denise, Gee, Julia M. W., Robertson, John F., Ellis, Ian O., Nicholson, Robert I.
Publicado 2018